Neumora Therapeutics
NMRA
NMRA
93 hedge funds and large institutions have $627M invested in Neumora Therapeutics in 2024 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 42 increasing their positions, 13 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
6.85% more ownership
Funds ownership: 33.17% → 40.01% (+6.8%)
6% more funds holding
Funds holding: 88 → 93 (+5)
14% less capital invested
Capital invested by funds: $725M → $627M (-$98M)
Holders
93
Holding in Top 10
5
Calls
$1.81M
Puts
$797K
Top Buyers
| 1 | +$35.6M | |
| 2 | +$28.9M | |
| 3 | +$14.9M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.2M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$8.19M |
Top Sellers
| 1 | -$13.8M | |
| 2 | -$9.47M | |
| 3 | -$3.88M | |
| 4 |
PC
Pier Capital
Stamford,
Connecticut
|
-$3.43M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$3.03M |